FREMONT, Calif. and
WALTHAM, Mass., Nov. 11, 2021 /PRNewswire/ -- Ardelyx, Inc.
(Nasdaq: ARDX), a biopharmaceutical company focused on the
discovery, development, and commercialization of innovative
first-in-class medicines to improve treatment for people with
kidney and cardiorenal diseases, today announced that Mike Raab, president and chief executive officer
of Ardelyx, will participate in a fireside chat at the Jefferies
London Healthcare Conference, which is taking place virtually and
in-person on November 16 – 19, 2021.
The fireside chat will be available to all registered participants
on-demand between 3:00 a.m. ET on
November 18, 2021 and 12:00 p.m. ET on November
19, 2021.
To access the webcast of Ardelyx's presentation please visit the
Events and Presentations page within the Ardelyx website at
https://ir.ardelyx.com/events-and-presentations. A replay of the
fireside chat will be available on the Ardelyx website for 30 days
following the presentation.
About Ardelyx, Inc.
Ardelyx is focused on discovering, developing, and
commercializing innovative first-in-class medicines to enhance the
lives of patients with kidney and cardiorenal diseases. Ardelyx is
developing tenapanor, a novel product candidate to control serum
phosphorus in adult patients with CKD on dialysis, which has
completed three successful Phase 3 trials. Ardelyx is also
advancing RDX013, a potassium secretagogue, for the potential
treatment of elevated serum potassium, or hyperkalemia, a problem
among certain patients with kidney and/or heart disease and has an
early-stage program in metabolic acidosis, a serious electrolyte
disorder in patients with CKD. In addition, tenapanor has already
received FDA approval for the treatment of irritable bowel syndrome
with constipation (IBS-C) under the tradename IBSRELA®.
Ardelyx has established agreements with Kyowa Kirin in Japan, Fosun Pharma in China, and Knight Therapeutics in Canada for the development and
commercialization of tenapanor in their respective territories.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ardelyx-to-present-at-the-jefferies-london-healthcare-conference-301422612.html
SOURCE Ardelyx